SwissMedic-2021-0049-V149
Type IB variation for application SwissMedic-2021-0049. Type IB variation: Labeling Change for Atezolimumab-R — critical change
Variation Number
SwissMedic-2021-0049-V149
Type
Type IB
Application
Change
Status
Submitted
Fee
€1,884
Submitted
—
Approved
—
Description
Type IB variation: Labeling Change for Atezolimumab-R — critical change